Geneva, Aug. 31 -- International Clinical Trials Registry received information related to the study (NCT07779226) titled 'DecNef for AVH in Schizophrenia' on Aug. 19.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: Double (Participant, Investigator).
Primary Sponsor: New York State Psychiatric Institute
Condition:
Schizophrenia Disorder
Schizoaffecitve Disorder
Intervention:
Device: Decoded Neurofeedback
Recruitment Status: Not recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: September 1, 2026
Target Sample Size: 51
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07779226
...